Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eldonet is a nutraceutical supplement developed and marketed by El Dorado Bio Tech, primarily positioned for cardiovascular and diabetic health. It is a combination product typically composed of the active forms of B-vitamins: **L-methylfolate**, **methylcobalamin** (Vitamin B12), and **pyridoxal-5-phosphate** (Vitamin B6). These components work synergistically to regulate homocysteine levels, which is critical for managing complications such as diabetic neuropathy and reducing cardiovascular risk. As a nutraceutical, it is intended to provide metabolic support and promote nerve health by bypassing the metabolic conversion steps required by synthetic vitamin forms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eldonet.